Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and Anoxemia

olmesartan has been researched along with Anoxemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bin, J; Cao, S; Chen, B; Fu, Y; Huang, Q; Huang, X; Kitakaze, M; Liao, Y; Lu, D; Xu, D; Zhang, J1
Hayashi, T; Kitada, K; Kitaura, Y; Matsumoto, C; Matsumura, Y; Miyamura, M; Mori, T; Okada, Y; Sohmiya, K; Ukimura, A; Yamashita, C; Yoshioka, T1
Chetsurakarn, S; Eiam-Ong, S; Limkuansuwan, P; Manotham, K; Ongvilawan, B; Tanamai, J; Tungsanga, K; Urusopone, P1
Arakawa, N; Fujimori, I; Inoue, T; Nakamura, H; Shimakawa, E; Shimizu, Y; Toyoshi, T; Yokoyama, T; Yoshigae, Y1
Hayashi, T; Kitaura, Y; Kwak, CJ; Matsumura, Y; Mori, T; Nakano, D; Okada, Y; Sohmiya, K; Tazawa, N; Yamashita, C1

Other Studies

5 other study(ies) available for olmesartan and Anoxemia

ArticleYear
Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53.
    British journal of pharmacology, 2014, Volume: 171, Issue:15

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Cells, Cultured; Fibroblasts; Growth Differentiation Factor 15; Heart Rupture; Hypoxia; Imidazoles; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Peroxidase; Tetrazoles; Tumor Suppressor Protein p53

2014
Efficacy of olmesartan and nifedipine on recurrent hypoxia-induced left ventricular remodeling in diabetic mice.
    Life sciences, 2010, Feb-27, Volume: 86, Issue:9-10

    Topics: Animals; Diabetes Mellitus, Type 2; Dietary Fats; Drug Therapy, Combination; Hypoxia; Imidazoles; Male; Mice; Mice, Obese; Myocytes, Cardiac; Nifedipine; Secondary Prevention; Tetrazoles; Ventricular Remodeling

2010
Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study.
    Internal medicine journal, 2012, Volume: 42, Issue:4

    Topics: Adult; Angiotensin Receptor Antagonists; Diabetic Nephropathies; Female; Humans; Hypoxia; Imidazoles; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Renal Insufficiency, Chronic; Tetrazoles; Young Adult

2012
Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models.
    European journal of pharmacology, 2005, Apr-11, Volume: 512, Issue:2-3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Area Under Curve; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Glycated Hemoglobin; Heart Rate; Hypertension; Hypoxia; Imidazoles; Male; Olmesartan Medoxomil; Oxygen; Rats; Rats, Inbred SHR; Retinal Neovascularization; Tetrazoles

2005
Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:12

    Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Heart Ventricles; Hypertrophy, Left Ventricular; Hypoxia; Imidazoles; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Knockout; Myocytes, Cardiac; NADPH Oxidases; NF-kappa B; Oxidative Stress; Superoxides; Tetrazoles; Ventricular Remodeling

2007